BACK
GLOBAL EXECUTIVE MOVES

November 2022
Areteia Therapeutics Appoints Christopher Courts as Chief Financial Officer
Areteia Therapeutics announced the appointment of Christopher Courts, CPA as Chief Financial Officer. Christopher is a seasoned industry executive with over 20 years of experience in public and private life science companies.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.